Mizuho Downgrades Apogee Therapeutics Inc (APGE) to Neutral

June 24, 2026 4:12 AM

Mizuho analyst Joseph Catanzaro downgraded Apogee Therapeutics Inc (NASDAQ: APGE) from to Neutral with a price target of $135.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found